CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$21.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$25.9M
2
+$17.9M
3
+$7.8M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$2.16M
5
VYNE icon
VYNE Therapeutics
VYNE
+$1.78M

Top Sells

1
+$15.9M
2
+$15.6M
3
+$14.5M
4
JANX icon
Janux Therapeutics
JANX
+$13.2M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$11.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$401M 29.86%
8,494,151
2
$78.3M 5.84%
8,325,000
3
$69.1M 5.15%
1,600,000
-400,000
4
$68.3M 5.09%
1,625,000
-120,000
5
$58.9M 4.39%
1,120,000
+380,000
6
$55.7M 4.15%
4,251,992
+150,000
7
$54.3M 4.05%
540,000
+15,000
8
$52.7M 3.92%
800,000
-250,000
9
$39.4M 2.93%
2,175,000
-650,000
10
$34.6M 2.58%
1,500,000
-500,000
11
$33.4M 2.49%
2,940,921
12
$33.1M 2.47%
+350,000
13
$30.9M 2.3%
2,909,000
14
$27.7M 2.06%
1,059,331
15
$27.4M 2.04%
2,086,600
-175,000
16
$25.6M 1.91%
1,454,660
-11,800
17
$24.5M 1.82%
2,009,482
18
$19.2M 1.43%
1,100,000
-500,000
19
$16.4M 1.22%
2,375,000
20
$16.3M 1.21%
2,130,000
21
$16.3M 1.21%
625,000
-150,000
22
$14M 1.04%
1,000,000
-350,000
23
$13.9M 1.04%
3,381,277
24
$12.2M 0.91%
300,000
-100,000
25
$11.5M 0.86%
400,000
-200,000
1
2